mammary analogue secretory carcinoma
GPTKB entity
Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
salivary gland tumor
|
| gptkbp:alsoKnownAs |
secretory carcinoma of salivary gland
MASC |
| gptkbp:canMetastasizeTo |
lymph nodes
distant organs (rarely) |
| gptkbp:differentialDiagnosis |
mucoepidermoid carcinoma
acinic cell carcinoma secretory carcinoma of the breast |
| gptkbp:firstDescribed |
2010
|
| gptkbp:hasGeneticAlteration |
gptkb:ETV6-NTRK3_gene_fusion
|
| gptkbp:histology |
microcystic, papillary-cystic, and solid patterns
|
| https://www.w3.org/2000/01/rdf-schema#label |
mammary analogue secretory carcinoma
|
| gptkbp:immunohistochemistry |
mammaglobin positive
S100 positive SOX10 positive vimentin positive |
| gptkbp:location |
gptkb:parotid_gland
|
| gptkbp:occurredIn |
submandibular gland
minor salivary glands |
| gptkbp:prognosis |
generally favorable
|
| gptkbp:similarTo |
secretory carcinoma of the breast
|
| gptkbp:treatment |
surgical excision
|
| gptkbp:WHOClassification |
recognized as a distinct entity in 2017
|
| gptkbp:bfsParent |
gptkb:ETV6-NTRK3_fusion
|
| gptkbp:bfsLayer |
8
|